49Indexed trials
Market Rank #44 · Evidence Tier A
South Africa
Neuroscience Intelligence
South Africa neuroscience intelligence: 49 indexed trials, 15 institutions, research score 24.98.
5Recruiting
15Research institutions
25.0Research score
Evidence profile
31Sponsors
13Disease areas
0Institution works
0Institution citations
Model signals
Opportunity 25 · ML priority 25 · Confidence 85 · Evidence 25.0
These are comparative evidence signals. They do not represent a guarantee of market size or commercial outcome.
Leading disease areas
parkinsons7trials
alzheimers5trials
depression5trials
pain_neuropathy4trials
autism4trials
stroke3trials
epilepsy2trials
schizophrenia2trials
bipolar_disorder2trials
multiple_sclerosis1trials
Leading indexed sponsors
Pfizer5trials
Merck Sharp & Dohme LLC4trials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4trials
Novo Nordisk A/S4trials
Sumitomo Pharma America, Inc.3trials
Bayer2trials
Forest Laboratories2trials
AbbVie2trials
Bial - Portela C S.A.1trials
Astellas Pharma Europe B.V.1trials